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Abstract
Background: Patient and public involvement is required where changes to care pro-
vided by the UK National Health Service are proposed. Yet involvement is character-
ized by ambiguity about its rationales, methods and impact.
Aims: To understand how patients and carers were involved in major system changes 
(MSCs) to the delivery of acute stroke care in 2 English cities, and what kinds of effects 
involvement was thought to produce.
Methods: Analysis of documents from both MSC projects, and retrospective in- depth 
interviews with 45 purposively selected individuals (providers, commissioners, third- 
sector employees) involved in the MSC.
Results: Involvement was enacted through consultation exercises; lay membership of 
governance structures; and elicitation of patient perspectives. Interviewees’ views of 
involvement in these MSCs varied, reflecting different views of involvement per se, 
and of implicit quality criteria. The value of involvement lay not in its contribution to 
acute service redesign but in its facilitation of the changes developed by professionals. 
We propose 3 conceptual categories—agitation management, verification and sub-
stantiation—to identify types of process through which involvement was seen to facili-
tate system change.
Discussion: Involvement was seen to have strategic and intrinsic value. Its strategic 
value lay in facilitating the implementation of a model of care that aimed to deliver 
evidence- based care to all; its intrinsic value was in the idea of citizen participation in 
change processes as an end in its own right. The concept of value, rather than impact, 
may provide greater traction in analyses of contemporary involvement practices.
K E Y W O R D S
impact, involvement, major system change, participation, stroke, value
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1  | INTRODUCTION
Internationally, citizens, patients and family carer- givers are increas-
ingly being positioned as collaborators in the labour required to pro-
duce and maintain health.1-5  This includes involvement in individual 
patient care, research, and planning, development and improvement 
of health services.6-8 Carman et al9 argue that such involvement 
challenges a dominant paternalistic approach to health care and sys-
tems and has the potential to transform patients, improve outcomes 
through better systems of care and reduce health- care costs. Yet 
involvement concepts and practices are characterized by ambiguity 
in terms of terminology,10,11 rationales,12,13 values14 and the attri-
butes of those who are invited or choose to be “involved”.13,15 The 
literature also suggests an anxiety that involvement aspirations are 
not being met as involvement practices are tokenistic rather than 
meaningful.16-19 What makes involvement meaningful or tokenistic 
has hardly been explained, but failure to involve in a “meaningful” 
way has been attributed to the different types of knowledge asso-
ciated with experts and lay people,20 and the privileging of expert 
over experiential knowledge.21 Involvement methods used have 
been criticized for their failure to adopt democratic models,16 en-
suring that traditional models of decision making are maintained.17 
Evidence that the promissory benefits of involvement in research 
and service development have been realized is limited, raising ques-
tions about not just how to evaluate impact but what impacts should 
be considered.22-24
In this paper, we consider the practices and achievements of 
patient and public involvement in major system change (MSC) that 
aimed to improve the delivery of acute stroke services in 2 met-
ropolitan cities, Greater Manchester (GM) and London in England. 
We draw on data from an evaluation of these MSCs that included 
investigation of how the requirement to involve patients, carers 
and the public25 was put into practice; and how involvement and 
its value were represented in interviews with those involved in 
service redesign. The meanings ascribed to involvement, we will 
argue, lay not in the diverse values thought to underpin involve-
ment14 but in the production of value arising from performances 
of involvement.
2  | MAJOR SYSTEM CHANGE
Major system change refers to large- scale reorganization of health 
services to create new care pathways and sometimes involving cen-
tralization of services with a reduction in the number of provider 
units.26 The aim is to improve care quality by making the most effi-
cient use of resources. Inevitably, MSC involves multiple stakeholders 
across different constituencies, with different interests.
A realist review of MSC initiatives identified 5 “simple rules” un-
derpinning successful initiatives.27 These were related to style of lead-
ership, development of feedback loops, learning from past experience 
and engagement of physicians. Rule 5 recommends the inclusion of 
patients and families, arguing “It is perhaps self- evident that the more 
service users that are involved in the change process, the more “pa-
tient centered” the services will become” (Best et al 2012, 441). We 
have previously proposed a more nuanced version of this “rule” that 
calls attention to how the various drivers of MSC can influence the 
weight of different stakeholders’ perspectives that may give rise to 
tension between patients’ and others’ perspectives.28
A rapid systematic review of studies investigating public engage-
ment (described as synonymous with involvement) in planning MSC 
interventions3 reported that there is no agreed definition of involve-
ment/engagement; a wide range of activities are used; studies have 
reported impact in terms of process but not outcome; and that it is 
not possible to isolate how engagement affects decision making or 
the kinds of MSCs that are implemented. The review called for further 
research to identify the impact of involvement in MSC and to isolate 
the most impactful methods of involving publics.
2.1 | MSC in stroke care
There have been significant advances in the evidence base of effective 
stroke care,29,30 and concerted policy drives to improve the quality of 
care. Yet national audit data suggested ongoing shortfalls in the delivery 
of best- quality acute care, with concerns about the proportions of pa-
tients being treated in a stroke unit or receiving clot- busting treatment 
(thrombolysis) where indicated. In London and GM, networks of clini-
cians and senior health service managers independently undertook to 
F IGURE  1 Care pathways before and after major system change
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re- organize stroke services to improve access to acute stroke care. They 
devised and in 2010 implemented 2 different models of the acute care 
pathway, both of which established hyperacute stroke units (HASUs) 
providing care over the first 72 hours after stroke, including rapid assess-
ment by specialized stroke medical teams, brain imaging and, if appropri-
ate, thrombolysis (clot- busting therapy). Patients were thereafter to be 
discharged or transferred to their local stroke unit for further treatment. 
In GM, only patients presenting within 4 hours of stroke would be ad-
mitted to a HASU; in London, all cases of suspected stroke were to be 
taken to HASU. Figure 1 presents the standard acute care pathway be-
fore MSC and the different pathways implemented in London and GM.
These were significant changes involving multiple organizations and 
large numbers of patients. In London, the previous acute stroke care sys-
tem involved 31 local commissioning organizations, 32 providers and the 
local ambulance service. In GM, the system involved 10 commissioning 
organizations, 9 providers and the ambulance service. In both areas, mul-
tiple agencies oversaw the development of and negotiations for the new 
centralized services over at least 2 years, with the work overseen by a 
specially instituted project boards, whose membership included provid-
ers, commissioners and patient representatives. Within 2 years of im-
plementing	the	new	centralized	models	of	care,	˃8000	stroke	patients	
were admitted to acute services in GM and 15 000 in London. There 
were concerns about the service change from the outset. Hospitals and 
professionals were concerned about implications of the new models of 
care in terms of loss of resources and in London the closure of 5 acute 
stroke wards. There were concerns about patient safety and acceptability 
since the new models meant journeys for some patients, beyond their 
locality, and transfers from one site to another. The need to engage all 
types of stakeholder was recognized if the proposed changes were to be 
implemented.
3  | METHODS
Data for this study were collected during a retrospective evaluation 
that investigated how changes in the delivery and organization of 
acute stroke care were implemented and to what effects. We draw 
on project documents and data from in- depth interviews with people 
involved in the implementation of the MSC. Interviews, which were 
conducted by (Author) and (Author) in 2012- 13, were designed to 
collect data on the entire process of change; in this paper, we focus 
specifically on participants’ accounts of how patient and public in-
volvement was enacted during the process of preparing for and im-
plementing the service changes.
Interviewees were purposively sampled to include a range of peo-
ple involved in the MSC at national and local levels (Table 1); they 
provided informed written consent. Interviews used a topic guide 
designed for the study; they were audio recorded and professionally 
transcribed in full. A separate analysis was conducted to investigate in-
volvement in MSC. All authors contributed to the data analysis, which 
was both inductive and deductive, as themes drew on both the a pri-
ori questions from the topic guide and those emerging from the data. 
Following initial coding of data, analysis sought to develop descriptive 
categories (for example of what kinds of involvement strategies were 
implemented) and then conceptual categories to propose a new inter-
pretation of data. The findings, analysis and interpretation were re-
fined in group discussions among AR, CP, SJT, NJF, RB and CM. Initial 
findings were also shared with the study advisory group to check for 
accuracy and the face validity of the interpretation being proposed.
4  | RESULTS
4.1 | Participants
In- depth interviews were conducted with 17 people in GM and 26 
in London leading and involved at board level in the system change 
process, including, NHS commissioners and managers, clinicians deliv-
ering acute care in the 2 settings and employees of stroke voluntary 
sector organizations.
4.2 | Involvement practices
Documentary analysis and interview data suggested that in both 
sites, multiple strategies were used to involve patients at a range 
Interviewees London GM National Total
Stroke network board 5 6 - 11
Pan- regional health authority 7 - - 7
Service commissioners 3 1 - 4
Service users or 
representatives
3 3 - 6
Programme facilitation 2 1 - 3
Clinical leads 2 1 - 3
Provider organizations 2 1 - 3
Stroke service staff - 3 - 3
Ambulance service 1 1 - 2
Local/national politicians 1 - 2 3
Total 26 17 2 45
TABLE  1 Profile of interviewees
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of levels. Existing resources were accessed (such as NHS involve-
ment managers and individual voluntary sector organizations); so-
cial and other media were used to invite patients to participate. In 
London, an involvement strategy was developed that outlined plans 
to access a range of public and patient groups and highlighted the 
need to access “hard- to- reach” groups. Interviewees in both areas 
identified different types of activity through which patients and 
public were involved as follows: stakeholder information and con-
sultations events; lay membership of governance structures; and 
formal elicitation of patient perspectives post- implementation. No 
similar single strategy document was developed in GM, but project 
documents, such as that detailing the governance framework, iden-
tified the organizational structures through which patient and public 
involvement, and public awareness and education would be devel-
oped and implemented.31
4.2.1 | Information and consultation events
In GM, 3 “stakeholder engagement events” were organized over 
8 months between 2007 and 08, as service development plans 
were initiated and took shape. The aims of these events reflected 
the development of plans for service change. Initially, they sought 
to get agreement about the need for change, then to inform stake-
holders about the planned changes and then to inform them about 
progress. Involvement was also described as making use of exist-
ing PPI structures—such as Stroke and Cardiac Networks and NHS 
Patient Advisory Liaison Services, and public health campaigning 
work into which information about the stroke service changes could 
be incorporated.
Consultations in London were much more extensive than in GM 
as these took place under the aegis of the larger regionwide review 
of health needs across a range of conditions and of current provisions 
of health care. The well- funded consultation programme, Healthcare 
for London—Consulting the Capital,32 sought views of members of the 
public on the range of proposals put forward in the resulting docu-
ment, Healthcare for London: A Framework for Action.33 The consul-
tation process was developed, overseen and analysed by Ipsos MORI, 
and used a range of marketing and opinion- seeking activities, includ-
ing online media, presentations to lay and professional organizations, 
and consultation road shows at health authority level.34 The formal 
consultation received 4734 responses (in online, written, email and 
other formats) from a wide range of stakeholders that included not 
only individual members of the public but also local voluntary sector 
organizations, local council members, health and other professional 
bodies, and local politicians. Comparison between individuals who 
took part and the London population found some differences with 
over- representation of women and older people; however, “the eth-
nic profile of respondents was broadly representative of Londoners” 
(Ipsos MORI 2009, 17).
The consultation had a clearly defined scope, concerning “Adult 
services for acute stroke care—explicitly the location and coverage of 
hyperacute services and acute services in London.” In response to the 
question about the proposal “to create more specialized centres for 
the treatment of severe injury, stroke and complex emergency surgery 
needs” 42% “strongly” agreed with the proposal to create more stroke 
specialist centres, and 25% tended to agree.33
A separate consultation process was subsequently held focus-
ing on proposed changes for acute stroke and trauma service, at a 
cost of £1.2 million. Again, this entailed preparation of consultation 
materials, numerous public events and formal elicitation of views. It 
was estimated that participation in the consultation involved 14 000 
individual visitors to the website, 13 000 visitors to health fairs and 
around 14 000 people attending meetings. Responses to the consul-
tation document were received from 8100 individuals and 200 orga-
nizations. It was reported that 67% of respondents strongly agreed/
tended to agree with the proposed model of acute stroke care that had 
been developed, that is that “about seven hospitals” across London 
should provide HASU care.34
4.2.2 | Membership of governance structures
Interviewees pointed to lay membership of governance bodies as a 
way in which involvement policy was implemented. In GM, a local ac-
tivist (spouse- carer of someone who had had a stroke in the past) and 
well known to professionals leading the service change was invited 
to join a working group and the Stroke Network Board, to which it 
reported. An employee of the Stroke Association and an NHS network 
PPI manager were also members of this Board. Similarly, in London, 
Stroke Association (a charity sector organization and service provider) 
employees sat on the project board and Clinical Expert panel which 
designed the service specifications to provide patient/carer repre-
sentation. Additionally, a Stroke Patient and Carer subcommittee was 
established to discuss topics including approaches to PPI, the running 
of consultation events and the development of the new model of care, 
and to feedback to the user groups they represented. This subcom-
mittee met 4 times during the life of the development process.
4.2.3 | Eliciting patient perspectives post- 
implementation
Interviewees also identified collecting patient and carer views of the 
new service as a form of involvement. For example, 12 months into 
the delivery of the newly reconfigured acute stroke pathway in GM, 
a review was conducted that included a separate study using survey 
and a series of qualitative interviews to elicit patient and carer views 
of the new pathway. Stroke survivors were invited to take part via 
online and social media, and through contacts with and visits to sup-
port groups across the region. In total, 84 people (10% response rate) 
returned the questionnaire, largely expressing the view that being ad-
mitted to a specialist acute centre, rather than the local hospital was 
not a concern.
4.3 | The quality of involvement
Our interviews did not ask participants to comment on whether in-
volvement was meaningful or tokenistic, but many offered their own 
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views of the quality of what was done, with wide variations in their 
appraisals.
Interviewees suggested that in GM there was little formal consul-
tation of patients and the public. Public events were described as de-
signed to provide information about the planned changes rather than 
to elicit views. For example, a commissioner said,
I don’t think at any stage we said to the public of Greater 
Manchester, if there’s such a thing – and there isn’t – we 
didn’t say, “Do you want three of these of five of these?” 
We never said that.  (GM01)
In London, where there were sustained efforts to hold formal con-
sultations 2 of 3 NHS managers interviewed were positive about the 
consultations because of the efforts made to encourage high levels of 
participation, and to be inclusive. An interviewee from the voluntary 
sector challenged this view, arguing consultation was not sufficiently 
accessible to people with stroke- related aphasia, for example. Others 
suggested the consultation was useful because it secured buy- in from 
the public or “political legitimacy.” However, one commissioner, who 
conceded that consultation was necessary because of societal expecta-
tions of transparency in public services, also expressed concerns about 
the limits of the public’s knowledge to comment on proposed new plans. 
Others, including a commissioner and 2 doctors were either dubious, 
expressing doubt about the usefulness or validity of consultation, or 
considered it “a complete waste of time” (L02) because consulting the 
public had eclipsed the need to consult more widely with professionals 
providing long- term services to stroke survivors.
There were also different evaluations of individuals’ contribu-
tions to governance structures. Several interviewees from GM spoke 
about the lone activist who was appointed to the project board as 
effective because of previous professional political experience, his 
ability in committee work, history as a campaigner for stroke ser-
vice quality and even his challenging approach. Others rehearsed 
well- known arguments about the limits of individual contributions 
because they were “self- selected,” or the “usual suspects” and there-
fore unrepresentative or because they lacked experience in formal 
committee work.
The limits of how actively involved lay people could be in this in-
volvement process were also recognized. For some, this was related to 
the nature of MSC itself. It required knowledge of a range of complex 
problems such as population needs, and resource implications and 
political implications. As the designs had been worked out by a core 
group of professionals, there was limited opportunity for lay people to 
influence the service design. For some interviewees, this meant that 
there was “no real involvement” while others conceded that while this 
might not be patient- led involvement, consultation processes allowed 
patients to become “advocates for the model.”
The trope of the patient voice also figured in interviewees’ ac-
counts. Involvement was seen as an opportunity for the patient voice 
to be articulated, represented by interviewees as an important correc-
tive to the dominant perspectives of professionals and organizations. 
For example, a physician said:
People (professionals) have to, really have to be brought 
back to what’s best for the patients and an awful lot of 
what gets discussed in the NHS is not about that, it’s 
about what’s best for my organisation.  (GM05)
On the other hand, a minority of interviewees argued while patient 
voices may have been heard, they could not be acted on within the scope 
of the consultation activities which were specifically limited to the MSC 
projects’ redesign of acute stroke services. Nevertheless, these interview-
ees noted that patients took the opportunity to articulate another concern: 
the quality of rehabilitation services. A manager clearly made this point:
… every single question which was asked in the half hour 
or so that the meeting was thrown open for questions from 
the floor was about rehab […] Nobody asked a question or 
protested about the decisions we were making about, er, 
the hospital service but all the members of the public and 
their representative questions were about rehab.  (L03)
Patients may have been content to leave acute service design to 
professionals who carefully made a convincing case for centralization as 
able to deliver better quality acute care for all. Yet the question of reha-
bilitation services was outside the brief of change leads, and even where 
involvement permitted dialogue between stakeholders, the question of 
rehabilitation and longer- term care was inadmissible.
4.4 | Constructing value
It could not therefore be argued that involvement in these examples of 
MSC influenced or improved the design of the acute stroke services. 
As we have previously argued, involvement was used instrumentally 
by programme leaders to gain support for change the case for which 
had already been made, and for service models already developed. 
For a minority of interviewees, this indicated a failure to achieve an 
ideal of patient- led involvement, but for most, even if flawed, the 
practices of involvement had intrinsic value for the implementation 
of MSC. We identify 3 types of value the interview data suggest.
4.4.1 | Managing agitation
First, involvement was represented as a way of managing actual or 
potential resistance or agitation.35 Above, we report the significance 
attributed to a lone activist in GM who had a track record in agitat-
ing for improved stroke services, after his wife’s own stroke. While 
interviewees recognized his expertise, he was also described as “grit 
in the system,” an irritant that produces change. In this case, it could 
be argued that there was an effort to manage an activist’s agitation by 
incorporating him into official PPI structures.
At a broader level, we have already seen that MSC leads were con-
cerned that patients and families might object to an acute care model 
that saw the patient being admitted to a non- local hospital and care 
involving ambulance transfers from one hospital. Thus, involvement 
sought to anticipate and manage any dissent that might arise.
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As Martin36 has argued, PPI could be a way of containing and man-
aging citizen desires and action yet PPI itself might give rise to unantic-
ipated forms of agitation, as happened in 2 localities in London, where 
local people and politicians objected to loss of local acute stroke 
services. Here, the MSC leads could point to the consultation work 
conducted across London as gathering “overwhelming support from 
everywhere else” (L03), thus trumping what could be portrayed as 
local interests. Indeed, the London model was consistently portrayed 
as pan- London, rather than locality based.
4.4.2 | Verification
Involvement was also described as permitting what could be 
termed processes of verification that took place at different levels. 
Interviewees suggested that involvement permitted the pre- empting 
of potential concerns patients and their family members might have 
about the fact that the new service might see them admitted to a 
specialist centre that was not their local hospital. This had been per-
ceived as a potential source of disagreement or dissatisfaction among 
patients. As such, opposition remained limited, and MSC leads were 
able to verify that their proposed design was acceptable to patients. 
Secondly, interviewees cited examples of how lay people had been 
involved in the development of information materials. For example, 
the work in GM entailed development of information for ambulance 
crews instructing them on the new procedures for suspected stroke 
admissions. Patient input was sought here on the development of 
scripts to be used by ambulance crew taking patients to a specialist 
centre, rather than the local hospital. Similarly, interviewees reported 
that involvement processes enabled them to be reassured that MSC 
was the right way to proceed. For example, one interviewee reflected:
… it was really important to be able to have their voice, 
saying ‘This is a good thing. It should be done’.  L03
4.4.3 | Substantiation
Finally, interviewees evoked an effect that we refer to as substantia-
tion, making an idea physically present. Involvement processes enabled 
the service user simply to be present in the room (as Donaldson37 puts 
it) or at a public event. By being present, the service user embodied 
the “stroke patient,” as a representative in a symbolic sense rather than 
representative in any population/demographic sense in a way that was 
useful for several reasons. First, the physical presence of the patient re-
lates to the normative status of involvement noted by previous authors: 
by being present in the room, patients provided physical evidence that 
involvement policy was being enacted. Thus, presence enabled dem-
onstration of adherence to the NHS vision that health- care develop-
ment depends not just on “technocratic intervention and political whim 
but also upon social values pertaining to equality, inclusion and social 
justice” (Milewa38, 250). A stroke physician interviewed described the 
development of a mission statement at the outset of the work which 
asserted that the purpose of the MSC was to ensure equality of access 
to the best possible acute care for every stroke patient:
I thought we should be really clear what it is we were here 
for and we wrote it on a flip chart and it came out at every 
meeting and it got stuck up on the wall. Every citizen of 
Greater Manchester has equal access to high quality acute 
stroke care. And actually, that was really useful because 
when the arguments started you could then say, but how 
does that relate to our vision?  (GM05)
Second, the patient’s presence in the room was used to manage con-
flict between professionals faced with decisions that might have conse-
quences for individuals, services or localities. The patient in the room was 
used to remind stakeholders that the ultimate goal was to improve the 
quality of patient care.
So… we’re bringing the focus back to the patient… and what 
we’re here for. We’re not here to be arguing about politics and 
you know, who’s the best stroke physician and, you know, peo-
ples’ ego; it’s about you know what would you want for your 
grandma or your mum if she had a stroke tomorrow.  (GM13)
Whenever we had stakeholder events, you know, we would 
always have a speaker who was either a carer or someone 
from the stroke association or occasionally a patient… and 
again it meant right down at a kind of micro level, people 
remembered we were doing this to improve patient care, 
not to protect their institution or their profession.  (L16)
Though seen as effective, it could also be argued that these instances 
of substantiation had the effect of reasserting the status of both patient 
and professional. The patient is recast as beneficiary of the work to im-
prove quality of care, and the professional as expert provider of benefit. 
The traditional roles of patient and expert are maintained. In this way, 
the emancipatory vision of involvement as transforming roles through 
empowerment does not appear to have been realized.
5  | DISCUSSION
This study drew on project documents and qualitative interviews with 
a wide range of professionals engaged in complex and protracted pro-
cesses to redesign acute stroke care in 2 English cities. The case for 
MSC was constructed by professionals drawing on clinical and manage-
rial experience, and examination of population- level patient data that 
demonstrated the need to improve access to best evidence care. This 
was consistent with NHS strategic guidance that requires service- level 
changes to be clinically led and underpinned by clinical evidence.39 This 
set the parameters of involvement from the outset: the case for change 
was professionally led, but the co- operation and approval of a wide 
range of stakeholders including clinical staff, NHS managers and local 
politicians was required. Patient and public involvement was a tool to 
facilitate implementation of the changes. In this sense, involvement 
could be seen as instrumental, achieving the outcomes desired by pro-
fessionals. However, we would further argue that rather than either 
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“tokenistic”—suggesting a cynical position, or “meaningful”—implying 
conformity with some a priori agreed definition of what involvement 
means—involvement here was enacted in strategic ways.
Interviewees’ accounts varied widely in how they evaluated involve-
ment. Consultations were seen as at worst a waste of time, to at best 
wide- reaching, inclusive events in which the patient voice could be heard 
and professional transparency demonstrated. The contribution of individ-
uals taking part in governance structures was also differently viewed. They 
were variously portrayed as powerful voices reminding professionals—at 
risk of promoting their own interests—of their true purpose; as making a 
limited contribution because of their limited competence in meeting be-
haviour; and as self- selected and unrepresentative.
This implies that professionals controlled not only the agenda but 
also the manner in which involvement was enacted.16,40 This may be in-
evitable. The model of involvement that dominates the NHS requires 
professionals to invite lay people to participate in activities which profes-
sionals design, focused on questions they identify. This differs from the 
involvement’s political antecedents: self- organizing patient movements, 
which drew on principles of social justice and emancipatory practice 
to challenge biomedical definitions of illness and solutions, counter- 
discrimination and stigma, and call for action into emergent health prob-
lems.41 While involvement may promise a transformation in relations 
between patients and professionals, as Komporozos et al42 have argued, 
the ritual nature of PPI activities constitutes “a conservative form of en-
gagement in health” (2016, 15) that serves to reinforce existing statuses, 
neutralizing the transformational potential of involvement.
Our data are limited in that they are retrospective, rather than con-
temporaneous accounts. The diversity of interviewees and their role in 
MSC means that each provides something of a partial view of which 
activities were undertaken and by whom. What emerges is a rather 
complex picture of diverse activities from information- giving events 
through to research to collect accounts of patient experience—framed 
by participants as involvement. The data do not necessarily provide an 
accurate historical record of PPI in the 2 MSC projects, but they offer 
a moral account of implementing PPI in the projects.
Our study offers lessons for thinking about involvement in gen-
eral and in relation to MSC. In particular, the findings represent a 
challenge to contemporary concerns that the literature reports 
processes of involvement but fails to report on impact and that 
improved methods to demonstrate impact are required.3,43 Our in-
terviewees’ accounts did not suggest that it was possible to demon-
strate impact of involvement in a linear way, because involvement 
was not designed to effect but to support change. Involvement here 
was a strategically symbolic process that served to use the moral au-
thority of the imagined but substantiated patient to support change 
implementation. Thus, involvement as enacted also reiterated the 
significance of involvement itself. Conklin et al23 and Li et al24 have 
suggested that rather than focus on impact, we should consider the 
quality of involvement in processual terms, either as democratic acts 
in their own right or strategic acts of informing and legitimizing.
Our study also finds limits to involvement as democratic process. 
The MSC sought to effect change in acute stroke care, and this set the 
parameters of what was admissible; consequently, patients’ concerns 
about the quality of care needed after discharge from hospital were 
rendered irrelevant. In London, the need to consider the whole stroke 
pathway was acknowledged by Health Care for London,34 but this ac-
knowledgement was made after the event; and it did not lead to sus-
tained effort to effect MSC in the priority area identified by patients.
Nevertheless, most participants in the study believed that involve-
ment activities had intrinsic value, facilitating the implementation of 
MSC. The value attributed to involvement sustained the idea of in-
volvement itself since as the anthropologist Graeber44 has remarked, 
value can be considered as the way in which specific activities are made 
meaningful to those involved. Investigating how value is  produced—and 
for whom—through involvement might offer a way of rethinking impact 
assessment in involvement which Edelman and Barron22 have faulted 
for treating this as if it were an intervention in its own right, rather than 
integral to a larger process. As these authors suggest, rethinking impact 
requires revisiting the goals and purpose of involvement. This study fur-
ther suggests a need to identify which goals and purposes are shared 
by different constituencies as we do not know whether patients and 
the public who were involved in MSC in London and GM would have 
recognized the value that emerged from our interviewees’ accounts.
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